17 records – page 1 of 1.

Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)

https://policybase.cma.ca/link/policy11297
Date
2014-10-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-17 An Act to amend the Food and Drugs Act

https://policybase.cma.ca/link/policy11196
Date
2014-06-11
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-45: The Cannabis Act

https://policybase.cma.ca/link/policy13723
Date
2017-08-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Canada’s lower-risk cannabis use guidelines (LRCUG)

https://policybase.cma.ca/link/policy13726
Date
2017-05-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase

https://policybase.cma.ca/link/policy11129
Date
2014-05-15
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA response to patented medicines regulations consultations

https://policybase.cma.ca/link/policy13690
Date
2017-06-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/link/policy13641
Date
2017-04-07
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety

https://policybase.cma.ca/link/policy11125
Date
2014-03-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA submission to the study of Bill C-37

https://policybase.cma.ca/link/policy13617
Date
2017-04-06
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the renewal of Federal Tobacco Control Strategy

https://policybase.cma.ca/link/policy13804
Date
2017-04-05
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Excise duty framework for cannabis products

https://policybase.cma.ca/link/policy13799
Date
2017-12-07
Topics
Pharmaceuticals, prescribing, cannabis, drugs

The Health risks and harms associated with the use of marijuana

https://policybase.cma.ca/link/policy11138
Date
2014-05-27
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Non-prescription availability of low-dose codeine products

https://policybase.cma.ca/link/policy13734
Date
2017-11-7
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Position statement on prescription drug shortages in Canada

https://policybase.cma.ca/link/policy10756
Last Reviewed
2017-03-04
Date
2013-05-25
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Policy Type
Policy document
Last Reviewed
2017-03-04
Date
2013-05-25
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Documents
Less detail

Proposed amendments to the marihuana for medical purposes regulations

https://policybase.cma.ca/link/policy11293
Date
2014-07-11
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations

https://policybase.cma.ca/link/policy11114
Date
2014-03-17
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Tamper Resistance under the Controlled Drugs and Substances Act

https://policybase.cma.ca/link/policy11295
Date
2014-08-26
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

17 records – page 1 of 1.